Pulmonx Corp — Director's Dealing 2024

Mar 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2024-03-15

Reporting Person: Williamson Steven S. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-15	Common Stock	A	205286	—	Acquired	205286	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-15	Employee Stock Option (right to buy)	$8.95	A	425116	Acquired	2034-03-14	Common Stock (425116)	Direct

Footnotes

F1: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest in accordance with the following schedule: 25% vests on March 3, 2025, and the remainder of the award vests in equal quarterly installments over the subsequent three-year period.

F2: Twenty-five percent of the shares subject to the option vests on March 3, 2025, and the remainder vests in equal monthly installments over the subsequent three-year period.